Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol

Francisca Verdugo-Paiva, Ariel Izcovich, Martín Ragusa, Gabriel Rada
doi: https://doi.org/10.1101/2020.04.11.20062109

Article usage

Article usage: April 2020 to October 2024

AbstractFullPdf
Apr 202016680409
May 20203390128
Jun 2020181069
Jul 2020125043
Aug 202071028
Sep 202052027
Oct 202031013
Nov 202046021
Dec 20202556
Jan 20213638
Feb 202158212
Mar 202146314
Apr 202173212
May 202158719
Jun 202166411
Jul 20213077
Aug 202143817
Sep 20212959
Oct 202128333
Nov 202136325
Dec 20212818
Jan 20223255
Feb 202221111
Mar 202221185
Apr 20223119
May 202254269
Jun 20222644
Jul 20221712
Aug 20222663
Sep 202229013
Oct 20221939
Nov 20221115
Dec 202212512
Jan 20231514
Feb 202312612
Mar 2023813
Apr 202316315
May 20231139
Jun 2023867
Jul 2023402
Aug 202321136
Sep 20231074
Oct 2023943
Nov 202317113
Dec 20231423
Jan 2024603
Feb 20241015
Mar 20245010
Apr 2024643
May 2024744
Jun 2024725
Jul 20248310
Aug 2024727
Sep 2024839
Oct 2024527
Back to top
Posted April 17, 2020.
Download PDF
Data/Code
Email
Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol
Francisca Verdugo-Paiva, Ariel Izcovich, Martín Ragusa, Gabriel Rada
medRxiv 2020.04.11.20062109; doi: https://doi.org/10.1101/2020.04.11.20062109
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area